RATIONALE: Pharmacological manipulation of serotonergic neurotransmission in healthy volunteers impacts on cognitive test performance. Specifically, markers of serotonin function are associated with attention and executive functioning, long-term memory, and general cognitive ability. The serotonin transporter (SERT) protein is a key regulator in the serotonin system. We hypothesized that higher performance on tests sensitive to serotonin would be associated with higher SERT levels in specific fronto-striatal brain regions. METHODS: Thirty-two healthy subjects (25 males, mean age 26.0 years, range 19-37) underwent positron emission tomography using the SERT ligand [(11)C]DASB. Subjects underwent the following tests: Stroop Color Word Test, Trail Making Test B, Rey's Auditory Verbal Learning Test and Complex Figure Test, logical reasoning subtest from Intelligenz-Struktur-Test 2000 R, and a Danish version of National Adult Reading Test. RESULTS: We found positive associations between performance on the Stroop Color Word Test and right-sided dorsolateral prefrontal SERT binding (R(2) = 0.12, p = 0.048). Furthermore, scores of logical reasoning (correlating with IQ) and educational level associated positively with SERT binding in the caudate, most prominent on the left side (logical reasoning: R(2) = 0.34, p = 0.0026 (left), R(2) = 0.2, p = 0.022 (right), educational level: R(2) = 0.19, p = 0.012 (left), R(2) = 0.15, p = 0.027 (right)). Scores of logical reasoning also associated with left-sided ventrolateral prefrontal cortex (R(2) = 0.24, p = 0.014). There were no significant associations between SERT binding and tests of long-term episodic memory. CONCLUSIONS: The results imply that in healthy subjects, high SERT binding in fronto-striatal regions is associated with better performance on tasks involving executive function and logical reasoning.
RATIONALE: Pharmacological manipulation of serotonergic neurotransmission in healthy volunteers impacts on cognitive test performance. Specifically, markers of serotonin function are associated with attention and executive functioning, long-term memory, and general cognitive ability. The serotonin transporter (SERT) protein is a key regulator in the serotonin system. We hypothesized that higher performance on tests sensitive to serotonin would be associated with higher SERT levels in specific fronto-striatal brain regions. METHODS: Thirty-two healthy subjects (25 males, mean age 26.0 years, range 19-37) underwent positron emission tomography using the SERT ligand [(11)C]DASB. Subjects underwent the following tests: Stroop Color Word Test, Trail Making Test B, Rey's Auditory Verbal Learning Test and Complex Figure Test, logical reasoning subtest from Intelligenz-Struktur-Test 2000 R, and a Danish version of National Adult Reading Test. RESULTS: We found positive associations between performance on the Stroop Color Word Test and right-sided dorsolateral prefrontal SERT binding (R(2) = 0.12, p = 0.048). Furthermore, scores of logical reasoning (correlating with IQ) and educational level associated positively with SERT binding in the caudate, most prominent on the left side (logical reasoning: R(2) = 0.34, p = 0.0026 (left), R(2) = 0.2, p = 0.022 (right), educational level: R(2) = 0.19, p = 0.012 (left), R(2) = 0.15, p = 0.027 (right)). Scores of logical reasoning also associated with left-sided ventrolateral prefrontal cortex (R(2) = 0.24, p = 0.014). There were no significant associations between SERT binding and tests of long-term episodic memory. CONCLUSIONS: The results imply that in healthy subjects, high SERT binding in fronto-striatal regions is associated with better performance on tasks involving executive function and logical reasoning.
Authors: J S Rubinsztein; R D Rogers; W J Riedel; M A Mehta; T W Robbins; B J Sahakian Journal: Psychopharmacology (Berl) Date: 2001-03 Impact factor: 4.530
Authors: Katherine L Narr; Roger P Woods; Paul M Thompson; Philip Szeszko; Delbert Robinson; Teodora Dimtcheva; Mala Gurbani; Arthur W Toga; Robert M Bilder Journal: Cereb Cortex Date: 2006-11-21 Impact factor: 5.357
Authors: John H Hughes; Peter Gallagher; Mary E Stewart; David Matthews; Tom P Kelly; Allan H Young Journal: J Psychopharmacol Date: 2003-09 Impact factor: 4.153
Authors: M Reimold; A Batra; A Knobel; M N Smolka; A Zimmer; K Mann; C Solbach; G Reischl; F Schwärzler; G Gründer; H-J Machulla; R Bares; A Heinz Journal: Mol Psychiatry Date: 2008-02-12 Impact factor: 15.992
Authors: Thomas Vanicek; Alexandra Kutzelnigg; Cecile Philippe; Helen L Sigurdardottir; Gregory M James; Andreas Hahn; Georg S Kranz; Anna Höflich; Alexander Kautzky; Tatjana Traub-Weidinger; Marcus Hacker; Wolfgang Wadsak; Markus Mitterhauser; Siegfried Kasper; Rupert Lanzenberger Journal: Hum Brain Mapp Date: 2016-10-22 Impact factor: 5.038
Authors: Elisabeth M Weiss; Günter Schulter; Andreas Fink; Eva M Reiser; Erich Mittenecker; Harald Niederstätter; Simone Nagl; Walther Parson; Ilona Papousek Journal: PLoS One Date: 2014-01-20 Impact factor: 3.240